When you join NOS as a Corporate Member you will be helping NOS reach our goals and objectives! The benefits to your organization include:

• Increased awareness of your products and services; 
• Gain recognition in the oncology marketplace;
• Communicate to key audience of cancer care professionals who make purchasing decisions for their practice;
• Establish an ongoing, brand-building relationship with physicians and their practices

We offer Gold and Platinum Corporate membership levels. For information about our corporate membership, please click here.

To obtain your corporate membership application form, click here, or contact Natalie Mandolfo.....your support is essential to our success!

 

Platinum member Amgen has released information on new drug indication for Prolia (denosumab).  Please click on the following links for the PI for Prolia and the Dear Doctor letter that corresponds to it 

 prolia_piA[1].pdf 

Dear_Doctor_E[2].docx

Other NEW drugs recently released from Genentech/Roche --  Zelboraf   

Pfizer -- Xalcori

 Celgene --- ISTODAX - please see the link for a letter for state societies  IST11018_PTCL_.pdf
7/14/11